Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), Technology (Time-lapse Microscopy, FRET, FRAP, HCS), End User (Pharma, Biotech, CROs) - Global Forecast to 2028

Abstract
The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the high/growing adoption of high-content screening techniques in drug discovery.

As drug discovery becomes increasingly reliant on high-throughput screening and HCS techniques, the demand for live cell imaging technology is likely to grow. This trend is expected to be particularly pronounced in the field of personalized medicine, where live cell imaging can be used to identify treatments tailored to individual patients.

“The consumables segment accounted for the second-largest share by product & service during the forecast period”

In 2022, consumables segment accounted for the second-largest share by product & service in the global live cell imaging market. Consumables include a range of products that are used in the imaging and analysis of live cells. These consumables play an important role in the live cell imaging workflow, as they are essential for sample preparation, maintenance, and analysis.

Consumables used in live cell imaging include reagents, media, assay kits, and other consumables such as microplates, slides, Petri dishes, coverslips, and culture chambers.

Consumables are typically disposable and need to be replenished regularly, making them an important recurring revenue stream for manufacturers. Consumables are an integral part of live cell imaging, and growth in this segment is mainly driven by the increasing demand for advanced imaging technologies and the growing adoption of live cell analysis in various research applications.

“Europe: The second largest region in the live cell imaging market”

Europe accounted for the second-largest market for live cell imaging after North America. The European live cell imaging market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of live cell imaging. This includes advancements in super-resolution microscopy, high-throughput imaging, single-cell imaging, and multi-modal imaging approaches.

The adoption of these innovative technologies accelerates the progress of live cell imaging research and expands its applications. Additionally, Europe offers comprehensive training and education programs in live cell imaging techniques. Universities, research institutes, and organizations provide specialized courses, workshops, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of training programs promotes the adoption and utilization of live cell imaging technologies in Europe.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side 20%
•By Designation: C-level - 45%, D-level - 30%, and Others - 25%
•By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%

List of Companies Profiled in the Report:
•Danaher (US)
•ZEISS Group (Germany)
•Nikon Corporation (Japan)
•Olympus Corporation (Japan)
•PerkinElmer Inc. (US)
•Sartorius AG (Germany)
•Agilent Technologies, Inc. (US)
•Thermo Fisher Scientific, Inc. (US)
•Etaluma, Inc. (US)
•CytoSMART Technologies (Netherlands)
•NanoEnTek Inc. (South Korea)
•GE Healthcare (US)
•Bruker Corporation (US)
•Becton, Dickinson and Company (BD) (US)
•Merck KGaA (Germany)
•Bio-Rad Laboratories, Inc. (US)
•Blue-Ray Biotech Corp. (Taiwan)
•CYTENA GmbH (Germany)
•Nanolive SA (Switzerland)
•Abberior (Germany)
•Phase Holographic Imaging (PHI) AB (Sweden)
•Cytoskeleton, Inc. (US)
•Corning Incorporated (US)
•KEYENCE Corporation (Japan)
•Aligned Genetics, Inc. (South Korea)

Research Coverage:
This report provides a detailed picture of the live cell imaging market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, application, technology, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges

The report provides insights on the following pointers:
•Analysis of key drivers (growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and growing availability of funds for research), restraints (High cost of high-content screening systems), opportunities (increasing adoption of live cell imaging technologies in emerging markets, and application of HCS in personalized medicine), and challenges (maintaining cell viability and cellular environment in cell cultures, and image analysis and data management) influencing the growth of the market.
•Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the live cell imaging market
•Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
•Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the live cell imaging market
•Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), Aligned Genetics, Inc. (South Korea), and among others in the market.

Content
Table of Contents

1INTRODUCTION41
1.1STUDY OBJECTIVES41
1.2MARKET DEFINITION41
1.2.1INCLUSIONS & EXCLUSIONS42
1.3MARKET SCOPE42
FIGURE 1LIVE CELL IMAGING MARKET SEGMENTATION42
1.3.1YEARS CONSIDERED43
1.4CURRENCY43
1.5LIMITATIONS43
1.6STAKEHOLDERS44
1.7SUMMARY OF CHANGES44
1.7.1RECESSION IMPACT45
2RESEARCH METHODOLOGY46
2.1RESEARCH DATA46
FIGURE 2RESEARCH DESIGN46
2.1.1SECONDARY DATA47
2.1.2PRIMARY DATA47
FIGURE 3LIVE CELL IMAGING MARKET: BREAKDOWN OF PRIMARIES48
2.2MARKET SIZE ESTIMATION49
FIGURE 4MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 202249
FIGURE 5MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 202250
FIGURE 6ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 202251
2.2.1INSIGHTS FROM PRIMARIES52
FIGURE 7MARKET VALIDATION FROM PRIMARY EXPERTS52
FIGURE 8MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH52
2.3GROWTH FORECAST53
FIGURE 9LIVE CELL IMAGING MARKET: CAGR PROJECTIONS, 2022–202854
FIGURE 10LIVE CELL IMAGING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES54
2.4MARKET BREAKDOWN AND DATA TRIANGULATION55
FIGURE 11DATA TRIANGULATION METHODOLOGY55
2.5RESEARCH ASSUMPTIONS56
2.6RISK ANALYSIS56
2.7RECESSION IMPACT ON LIVE CELL IMAGING MARKET56
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)57
TABLE 2US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)57
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)57
3EXECUTIVE SUMMARY59
FIGURE 12LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)59
FIGURE 13LIVE CELL IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)60
FIGURE 14LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)60
FIGURE 15LIVE CELL IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)61
FIGURE 16GEOGRAPHICAL SNAPSHOT OF LIVE CELL IMAGING MARKET62
4PREMIUM INSIGHTS63
4.1LIVE CELL IMAGING MARKET OVERVIEW63
FIGURE 17GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES IN DRUG DISCOVERY TO DRIVE MARKET GROWTH63
4.2NORTH AMERICA: LIVE CELL IMAGING MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022)64
FIGURE 18INSTRUMENTS DOMINATED NORTH AMERICAN LIVE CELL IMAGING MARKET IN 202264
4.3LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)65
FIGURE 19INSTRUMENTS TO CONTINUE TO DOMINATE MARKET BY 202865
4.4LIVE CELL IMAGING MARKET SHARE, BY END USER, 202265
FIGURE 20PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 202265
4.5LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES66
FIGURE 21ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN LIVE CELL IMAGING MARKET FROM 2023 TO 202866
5MARKET OVERVIEW67
5.1INTRODUCTION67
5.2MARKET DYNAMICS67
FIGURE 22LIVE CELL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES67
TABLE 4LIVE CELL IMAGING MARKET: IMPACT ANALYSIS68
5.2.1DRIVERS68
5.2.1.1Growing adoption of high-content screening techniques in drug discovery68
5.2.1.2Rising incidence of cancer69
TABLE 5ESTIMATED NEW CANCER CASES IN US, 202369
FIGURE 23GLOBAL CANCER INCIDENCE & MORTALITY, 202070
5.2.1.3Growing availability of research funds70
TABLE 6INVESTMENT BREAKDOWN, 2021 (USD MILLION)72
5.2.2RESTRAINTS72
5.2.2.1High cost of high-content screening systems72
5.2.3OPPORTUNITIES73
5.2.3.1Increasing adoption of live cell imaging technologies in emerging economies73
5.2.3.2Applications of HCS in personalized medicine73
5.2.4CHALLENGES74
5.2.4.1Maintaining cell viability and cellular environment in cell cultures74
5.2.4.2Image analysis and data management74
5.3TECHNOLOGY ANALYSIS75
5.4TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES76
FIGURE 24REVENUE SHIFT & NEW POCKETS FOR LIVE CELL IMAGING PRODUCT & SERVICE PROVIDERS77
5.5VALUE/SUPPLY CHAIN ANALYSIS77
5.5.1VALUE CHAIN ANALYSIS77
FIGURE 25LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS78
5.5.2SUPPLY CHAIN ANALYSIS79
FIGURE 26LIVE CELL IMAGING MARKET: SUPPLY CHAIN ANALYSIS79
5.6REGULATORY ANALYSIS80
5.6.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS80
5.6.1.1North America80
5.6.1.1.1US80
5.6.1.1.2Canada80
5.6.1.2Europe80
5.6.1.3Asia Pacific81
5.6.1.4Rest of the World81
5.7PORTER’S FIVE FORCES ANALYSIS82
TABLE 7LIVE CELL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS82
5.7.1THREAT OF NEW ENTRANTS82
5.7.2THREAT OF SUBSTITUTES82
5.7.3BARGAINING POWER OF SUPPLIERS82
5.7.4BARGAINING POWER OF BUYERS82
5.7.5INTENSITY OF COMPETITIVE RIVALRY83
5.8ECOSYSTEM ANALYSIS83
TABLE 8SUPPLY CHAIN ECOSYSTEM83
5.9PRICING ANALYSIS85
5.9.1AVERAGE SELLING PRICE, BY KEY PLAYER85
TABLE 9AVERAGE SELLING PRICES85
5.9.2AVERAGE SELLING PRICE TREND86
5.10KEY CONFERENCES & EVENTS IN 2022–202386
TABLE 10LIVE CELL IMAGING: DETAILED LIST OF CONFERENCES & EVENTS86
5.11KEY STAKEHOLDERS AND BUYING CRITERIA88
5.11.1KEY STAKEHOLDERS IN BUYING PROCESS88
FIGURE 27INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LIVE CELL IMAGING PRODUCTS88
5.11.2BUYING CRITERIA FOR LIVE CELL IMAGING88
FIGURE 28KEY BUYING CRITERIA FOR END USERS88
5.12PATENT ANALYSIS89
FIGURE 29LIVE CELL IMAGING MARKET: PATENT APPLICATIONS (JANUARY 2020–APRIL 2023)89
6LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE90
6.1INTRODUCTION91
TABLE 11LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)91
6.2INSTRUMENTS92
TABLE 12EXAMPLES OF INSTRUMENTS OFFERED BY MARKET PLAYERS92
TABLE 13LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)93
TABLE 14LIVE CELL IMAGING INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)93
TABLE 15NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)93
TABLE 16EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
TABLE 17ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
TABLE 18LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
6.2.1MICROSCOPES95
6.2.1.1Continuous technological advancements in microscopes to support market95
TABLE 19CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS96
TABLE 20CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS97
TABLE 21FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS98
TABLE 22LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY REGION, 2021–2028 (USD MILLION)98
TABLE 23NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 24EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 25ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 26LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR MICROSCOPES, BY COUNTRY, 2021–2028 (USD MILLION)100
6.2.2STANDALONE SYSTEMS100
6.2.2.1Seamless integration and workflow efficiency of standalone systems to boost demand100
TABLE 27STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS100
TABLE 28LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)101
TABLE 29NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)101
TABLE 30EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)101
TABLE 31ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)102
TABLE 32LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR STANDALONE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)102
6.2.3CELL ANALYZERS102
6.2.3.1Accuracy and reproducibility of cell analyzers to support growth102
TABLE 33CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS103
TABLE 34LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION)103
TABLE 35NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)103
TABLE 36EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)104
TABLE 37ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)104
TABLE 38LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION)104
6.2.4ACCESSORIES105
6.2.4.1Ability of accessories to optimize and enhance imaging conditions to boost demand105
TABLE 39ACCESSORIES OFFERED BY KEY MARKET PLAYERS105
TABLE 40LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION)106
TABLE 41NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)106
TABLE 42EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)107
TABLE 43ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)107
TABLE 44LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET FOR ACCESSORIES, BY COUNTRY, 2021–2028 (USD MILLION)107
6.3CONSUMABLES108
TABLE 45LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)108
TABLE 46LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)108
TABLE 47NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 48EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 49ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 50LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)110
6.3.1REAGENTS110
6.3.1.1Widespread usage in life science research to fuel market growth110
TABLE 51REAGENTS OFFERED BY KEY MARKET PLAYERS111
TABLE 52LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2021–2028 (USD MILLION)111
TABLE 53NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 54EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 55ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 56LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)113
6.3.2ASSAY KITS113
6.3.2.1Repeat purchase of assay kits to drive market113
TABLE 57ASSAY KITS OFFERED BY KEY MARKET PLAYERS113
TABLE 58LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2021–2028 (USD MILLION)114
TABLE 59NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 60EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)115
TABLE 61ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)115
TABLE 62LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2021–2028 (USD MILLION)115
6.3.3MEDIA116
6.3.3.1Increasing demand for optimized cell culture conditions to drive demand for media116
TABLE 63MEDIA OFFERED BY KEY MARKET PLAYERS116
TABLE 64LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY REGION, 2021–2028 (USD MILLION)116
TABLE 65NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 66EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 67ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)117
TABLE 68LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET FOR MEDIA, BY COUNTRY, 2021–2028 (USD MILLION)118
6.3.4OTHER CONSUMABLES118
TABLE 69OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS119
TABLE 70OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)119
TABLE 71NORTH AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)119
TABLE 72EUROPE: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 73ASIA PACIFIC: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 74LATIN AMERICA: OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)120
6.4SOFTWARE121
6.4.1TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION TO BOOST MARKET GROWTH121
TABLE 75SOFTWARE OFFERED BY KEY MARKET PLAYERS121
TABLE 76LIVE CELL IMAGING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)122
TABLE 77NORTH AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)122
TABLE 78EUROPE: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 79ASIA PACIFIC: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 80LATIN AMERICA: LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)123
6.5SERVICES124
6.5.1GROWING DEMAND FOR OUTSOURCED EXPERTISE AND SPECIALIZED SERVICES TO SUPPORT MARKET124
TABLE 81LIVE CELL IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)124
TABLE 82NORTH AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)125
TABLE 83EUROPE: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)125
TABLE 84ASIA PACIFIC: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)125
TABLE 85LATIN AMERICA: LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)126
7LIVE CELL IMAGING MARKET, BY APPLICATION127
7.1INTRODUCTION128
TABLE 86LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)128
7.2CELL BIOLOGY128
TABLE 87NUMBER OF NEW CANCER CASES, BY TYPE, 2020 VS. 2040129
TABLE 88LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)130
TABLE 89NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 90EUROPE: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)130
TABLE 91ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)131
TABLE 92LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CELL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)131
7.3STEM CELLS131
7.3.1GROWING FOCUS ON REGENERATIVE MEDICINE & ADVANCEMENTS IN STEM CELL RESEARCH TO BOOST MARKET131
TABLE 93LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)132
TABLE 94NORTH AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)132
TABLE 95EUROPE: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 96ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)133
TABLE 97LATIN AMERICA: LIVE CELL IMAGING MARKET FOR STEM CELL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)133
7.4DEVELOPMENTAL BIOLOGY134
7.4.1GROWING INTEREST IN UNDERSTANDING ORGANOGENESIS AND TISSUE MORPHOGENESIS TO DRIVE DEMAND134
TABLE 98LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)134
TABLE 99NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 100EUROPE: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 101ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)135
TABLE 102LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)136
7.5DRUG DISCOVERY136
7.5.1GROWING USE OF HCS CELL-BASED ASSAYS IN DRUG DISCOVERY STUDIES TO DRIVE DEMAND136
TABLE 103LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)137
TABLE 104NORTH AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)137
TABLE 105EUROPE: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)138
TABLE 106ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)138
TABLE 107LATIN AMERICA: LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)138
8LIVE CELL IMAGING MARKET, BY TECHNOLOGY139
8.1INTRODUCTION140
TABLE 108LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)140
8.2TIME-LAPSE MICROSCOPY140
TABLE 109LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY REGION, 2021–2028 (USD MILLION)141
TABLE 110NORTH AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)141
TABLE 111EUROPE: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 112ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)142
TABLE 113LATIN AMERICA: LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2021–2028 (USD MILLION)142
8.3FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET)143
8.3.1ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES TO BOOST ADOPTION OF FRET TECHNOLOGY143
TABLE 114LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY REGION, 2021–2028 (USD MILLION)143
TABLE 115NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)143
TABLE 116EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)144
TABLE 117ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)144
TABLE 118LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2021–2028 (USD MILLION)144
8.4FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)145
8.4.1INTEGRATION OF FRAP WITH LIVE CELL IMAGING MICROSCOPY TO CONTRIBUTE TO MARKET GROWTH145
TABLE 119LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY REGION, 2021–2028 (USD MILLION)145
TABLE 120NORTH AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 121EUROPE: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 122ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)146
TABLE 123LATIN AMERICA: LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2021–2028 (USD MILLION)147
8.5HIGH-CONTENT SCREENING (HCS)147
8.5.1GROWING ADOPTION OF HCS IN DRUG DISCOVERY AND TOXICITY SCREENING TO DRIVE GROWTH147
TABLE 124LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2021–2028 (USD MILLION)148
TABLE 125NORTH AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)148
TABLE 126EUROPE: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)148
TABLE 127ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)149
TABLE 128LATIN AMERICA: LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)149
 
8.6OTHER TECHNOLOGIES149
TABLE 129LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION)150
TABLE 130NORTH AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)150
TABLE 131EUROPE: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)151
TABLE 132ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)151
TABLE 133LATIN AMERICA: LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)151
9LIVE CELL IMAGING MARKET, BY END USER152
9.1INTRODUCTION153
TABLE 134LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)153
9.2PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES153
9.2.1NEED TO ADHERE TO STRICT REGULATIONS TO DRIVE USE OF LIVE CELL IMAGING PRODUCTS AMONG PHARMA COMPANIES153
TABLE 135LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)154
TABLE 136NORTH AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)154
TABLE 137EUROPE: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 138ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)155
TABLE 139LATIN AMERICA: LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)155
9.3ACADEMIC & RESEARCH INSTITUTES156
9.3.1INCREASING NUMBER OF DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH156
TABLE 140LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)156
TABLE 141NORTH AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)157
TABLE 142EUROPE: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)157
TABLE 143ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)157
TABLE 144LATIN AMERICA: LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)158
9.4CONTRACT RESEARCH ORGANIZATIONS158
9.4.1GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE DEMAND158
TABLE 145LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021–2028 (USD MILLION)159
TABLE 146NORTH AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)159
TABLE 147EUROPE: LIVE CELL IMAGING MARKET FOR F CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)160
TABLE 148ASIA PACIFIC: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)160
TABLE 149LATIN AMERICA: LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)160
10LIVE CELL IMAGING MARKET, BY REGION161
10.1INTRODUCTION162
TABLE 150LIVE CELL IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)162
10.2NORTH AMERICA162
FIGURE 30NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT163
TABLE 151NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)164
TABLE 152NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)164
TABLE 153NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)164
TABLE 154NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)165
TABLE 155NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)165
TABLE 156NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)166
TABLE 157NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)166
10.2.1US167
10.2.1.1US to dominate live cell imaging market in North America167
TABLE 158US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)167
TABLE 159US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 160US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)168
TABLE 161US: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)168
TABLE 162US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)169
TABLE 163US: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)169
10.2.2CANADA169
10.2.2.1Government initiatives to promote research to support market growth169
TABLE 164CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)170
TABLE 165CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)170
TABLE 166CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)171
TABLE 167CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)171
TABLE 168CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)171
TABLE 169CANADA: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)172
10.2.3NORTH AMERICA: RECESSION IMPACT172
10.3EUROPE173
TABLE 170EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)173
TABLE 171EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)174
TABLE 172EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)174
TABLE 173EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)174
TABLE 174EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)175
TABLE 175EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)175
TABLE 176EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)176
10.3.1GERMANY176
10.3.1.1Presence of large number of academic research institutes to boost market176
TABLE 177GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)177
TABLE 178GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)177
TABLE 179GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)178
TABLE 180GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)178
TABLE 181GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)179
TABLE 182GERMANY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)179
10.3.2UK180
10.3.2.1Investments by pharmaceutical sponsors for drug discovery services to support market180
FIGURE 31UK: PHARMACEUTICAL R&D EXPENDITURE, 2011–2020 (USD MILLION)180
TABLE 183UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)181
TABLE 184UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)181
TABLE 185UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)181
TABLE 186UK: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)182
TABLE 187UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)182
TABLE 188UK: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)183
10.3.3FRANCE183
10.3.3.1Large pharmaceutical manufacturing industry to drive market growth183
TABLE 189FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)184
TABLE 190FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)184
TABLE 191FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)185
TABLE 192FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)185
TABLE 193FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)186
TABLE 194FRANCE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)186
10.3.4ITALY186
10.3.4.1Strong research tradition, government funding, and collaborative research networks to fuel growth186
TABLE 195ITALY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)187
TABLE 196ITALY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)187
TABLE 197ITALY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)188
TABLE 198ITALY: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)188
TABLE 199ITALY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)189
TABLE 200ITALY: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)189
10.3.5SPAIN190
10.3.5.1Rising R&D expenditure to boost market190
TABLE 201SPAIN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)190
TABLE 202SPAIN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)190
TABLE 203SPAIN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)191
TABLE 204SPAIN: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)191
TABLE 205SPAIN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)192
TABLE 206SPAIN: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)192
10.3.6REST OF EUROPE192
TABLE 207REST OF EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)193
TABLE 208REST OF EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)193
TABLE 209REST OF EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)194
TABLE 210REST OF EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)194
TABLE 211REST OF EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)195
TABLE 212REST OF EUROPE: LIVE CELL IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)195
10.3.7EUROPE: RECESSION IMPACT196